Clinical Trials for John Greer

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticVICCHEM1284
06/05/2013
Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma
TherapeuticECOGBMTS0805
09/14/2011
Phase II Study of Combination of Hyper-CVAD and Dasatinib (NSC-732517) With or Without Allogeneic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.